In Law360, Cross-Office Team Analyzes President Trump’s Drug Pricing Plan

In The News
May 18, 2018
Thomas N. Bulleit

Partner Tom Bulleit (Washington, D.C.) co-authored a May 17 article in Law360 analyzing the Trump administration’s four-point plan for curbing prescription drug prices.

The authors break down the administration’s key proposals and likely paths forward, including assessing whether potential changes could be made quickly by administrative action, or are more likely to take more time and require legislation.


Thomas N. Bulleit
Thomas N. Bulleit
Retired Partner